ORTEXORTEX News
Tracking IMVT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IM

Immunovant, Inc. (IMVT) short interest & options flow

NASDAQ

Immunovant reports today with one of the most striking options signals in the biotech space: the put/call ratio has collapsed to 0.09, nearly 1.7 standard deviations below its 20-day average of 0.22, and close to its 52-week low of 0.05. That is unusually aggressive call-side positioning, with traders loading up on upside exposure rather than hedging into the release. The stock…

$31.77-2.31% 1d-7.05% 1w+11.12% 1mClose: 20 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Availability
Rising
Live availability on ORTEX →
Market cap
$6.57B
Next earnings
5 Feb 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 22 Nov 2026

ORTEX chart of Immunovant, Inc. (IMVT) share price and short interest (% of free float), six months to November 20, 2026

IMVT news and analysis

RSS

No long-form analysis yet for IMVT. Pulse alerts and the live data picture are available on ORTEX.

Open IMVT on ORTEX →

Want the live picture for IMVT?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IMVT — free to start on ORTEX.

Sign up for free →Open IMVT on ORTEX